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Abstract
Background: Bronchiolitis is considered one of the earliest and most common causes of hospitalisation in young
children. Development of molecular technologies allowed a better understanding of bronchiolitis aetiology. Results
from cohort studies evaluating the association between single, multiple viral infections and clinical outcomes are
conflicting. Data on viral bronchiolitis in children were found to be limited in Qatar. This study aimed to determine
frequency and seasonal trends of viral pathogens causing acute bronchiolitis, and to explore association between
viral pathogens, disease severity and length of stay (LOS).
Methods: This is a retrospective descriptive study, including children admitted in 2010 and 2011 with acute
bronchiolitis. Presenting history, physical examination and respiratory viral co-infections as detected by molecular
assays were analysed.
Results: At least one virus was detected in 315/369 (85.4%) of included children with single and multiple viruses
in 67 and 33% of cases respectively. Respiratory syncytial virus (RSV) was the most detected virus, accounting for 51.
2% followed by rhinovirus (RV) in 25.5% of cases. Fall and summer admissions were associated with longer LOS. On
multivariate logistic regression analysis, retraction (OR 3.96; 95% CI 1.64,9.59) and age group 1–3 months (OR 3.09;
95% CI 1.06,9.05) were associated with longer LOS. Crepitation (OR 9.15; 95% CI 1.58,53.13), retraction (OR 4.10; 95%
CI 1.05,16.12) and respiratory rate (OR 1.46; 95% CI 1.28,1.66) were associated with moderate to severe bronchiolitis.
Identifying the viral agent did not influence disease severity or LOS.
Conclusion: Clinical presentation is of more relevance to LOS and disease severity than the detected viruses. Future
studies should investigate the interplay between climate characteristics, population’s factors and the most detectable
circulating viruses.
Keywords: Length of stay, Bronchiolitis severity, Multivariate predictors
Background
Bronchiolitis is considered one of the earliest and
most common causes of hospitalisation among young
children during their first 2 years of life [1]. Although
the causative agents include bacteria, fungi and vi-
ruses, this acute infection is mainly attributed to re-
spiratory syncytial virus, accounting for 50–90% of the
cases [2, 3]. With the current utilisation of reverse
transcriptase real-time polymerase chain reaction
(PCR), the detection of specific viral nucleic acids
facilitated a better understanding of the viral aetiology
of the infection. The 2014 American Academy of
Paediatrics bronchiolitis guideline recommends against
the routine use of radiographic or laboratory studies
on the basis that knowing the infecting pathogen
would rarely alter the clinical management [4]. How-
ever, a growing body of literature has identified an
association between specific infecting pathogens with
short and long-term outcomes [5]. Association be-
tween viral co-infection and disease severity have been
assessed in several studies but with conflicting find-
ings [5–7]. Although bronchiolitis is a self-limiting
condition, hospitalisation rate has increased during
the last two decades [3]. Assessment of bronchiolitis
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severity, through a combination of clinical symptoms
and physical signs, remains a standard measure in
daily practice though its impact on clinical outcomes,
such as length of hospital stay, has yet to be con-
firmed. Data has been reported on seasonal variation
of viral activity with conflicting evidence on its signifi-
cance on disease severity and clinical outcomes [8, 9].
In Qatar, viral aetiology of bronchiolitis in children
has been limited. Therefore the aims of this retro-
spective, descriptive study were: to determine the fre-
quency and seasonal trends of viral pathogens causing
acute bronchiolitis, and to explore the association be-
tween specific viral pathogens, disease severity and
length of stay (LOS).
Methods
Study design
This retrospective descriptive study took place at the
paediatric wards of Hamad General Hospital (HGH), a
603- bed, tertiary-care facility in Doha, for two consecu-
tive years, 2010 and 2011. The institutional review board
at Hamad Medical Corporation approved the study, IRB
number 12054.
Study population
The study population included children aged between 2
weeks- 2 years admitted to the paediatric ward at HGH
with a diagnosis of acute bronchiolitis defined according
to International Classification of Disease (ICD) code
466.1 in the 9th revision of the ICD. Based on recorded
clinical diagnosis, an episode of acute bronchiolitis was
determined by a constellation of clinical signs and symp-
toms including fever, rhinitis, tachypnoea, cough, wheez-
ing, crackles, use of accessory muscles and possible
chest X ray findings of hyperinflation of the lungs,
peri-bronchial thickening, collapsed segment or a lobe
of the lung and increase interstitial markings. Due to
the potential for an atypical natural history of bron-
chiolitis, children with the following diagnoses were
excluded: born prematurely, defined as <37 weeks of
gestation, those with low birth weight, defined as birth
weight <2.5 kg, with underlying chronic lung disease or
neurological disease or congenital heart disease, and
those immunocompromised or with hospital-acquired
bronchiolitis.
Data collection
Medical charts of the children admitted to the paediat-
ric ward during the study period were retrieved from
the medical records department at HGH, a tertiary
teaching hospital located in Doha, Qatar. A trained re-
search staff screened patients’ discharge summaries
for diagnosis of bronchiolitis. A data collection form
(DCF) was developed to capture the necessary
information. For every child who met the inclusion
criteria the following data were collected: age, gender,
family history of asthma and/or atopy, clinical presen-
tation and vital signs upon admission and length of
hospital stay. Bronchiolitis severity was based on a
score ranging between 1 and 5 that assessed wheezing,
retraction, respiratory rate and oxygen saturation (see
Additional file 1: Table S1). Patients with score of 1 or
2 were considered to have mild bronchiolitis and to
have moderate to severe bronchiolitis if score was be-
tween 3 and 4, with 5 indicating respiratory failure.
Wheezing on physical exam was categorised as none,
mild, moderate or severe. Retraction was categorised
as none, intercostal, intercostal and subcostal or inter-
costal and subcostal with seesaw chest motion. Viral
identification laboratory results, medical therapy and
need of mechanical ventilation during hospital stay
were recorded. Hospital admissions due to bronchio-
litis were presented on an episode base.
Nasopharyngeal sample collection and analysis
Nasopharyngeal samples were collected by inserting
Dacron™ polyester tipped or FLOQSwab™ in both nos-
trils till the nasopharynx and rotating at 360°. The swabs
were placed into 3 ml of transport medium (Copan,
UTM-RT™, CA, USA). Following collection, samples
were kept on wet ice and transported to central process-
ing lab of HGH during the working hours. Specimens
that were not delivered immediately to the lab were
stored in a refrigerator (4 – 8 °C) for no more than 24 h.
Beyond that, samples were stored at -70 °C and trans-
ported on dry ice. EZ1 virus mini kit v 2.0, was used for
nucleic acid extraction (Qiagen®, Hilden, Germany).
Multiplex, real-time, polymerase chain reaction (RT-
PCR) using FTDResp21 kit (Fast Track Diagnostics,
Silema, Malta) was used for the detection of respira-
tory pathogens on Applied Biosystem™ 7500 instru-
ment (ThermoFisher Scientific Inc, MA, USA). The
kit detects the following respiratory pathogens: influ-
enza A and B; coronaviruses NL63, 229E, OC43 and
HKU1; parainfluenza viruses 1, 2, 3 and 4; human
metapneumovirus A/B (hMPV); rhinovirus (RV); re-
spiratory syncytial virus A/B (RSV); adenovirus (AdV);
enterovirus (EV); parechovirus (PeV); bocavirus (BoV)
and Mycoplasma pneumoniae (Mpneu).
Statistical analysis
The focus of the data analysis in our study was to de-
termine frequency of each virus that is causing acute
bronchiolitis in young children in our community and
link it to the clinical presentation, length of hospital
stay, severity of symptoms and need for intensive care
support including invasive and non invasive ventilation.
Categorical and continuous values were expressed as
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frequency (percentage) and mean ± SD or median and
interquartile range (IQR) as appropriate. Descriptive sta-
tistics were used to summarise demographic, medical his-
tory, frequency of each virus and clinical characteristics of
the patients. Associations between two or more qualitative
variables were assessed using chi-square test and Fisher
Exact test as appropriate. Quantitative data between the
two independent groups were analysed using unpaired ‘t’
and Mann Whitney U tests as appropriate.
Univariate and multivariate logistic regression methods
were used to assess and compute the predictive values of
each predictor or risk factors for severity of bronchiolitis
and hospital length of stay. For multivariate regression
models, variables were considered if statistically significant
at the P <0.10 level in univariate analysis or if determined
to be clinically important. The results of logistic regression
analyses were reported as odds ratio (OR) with 95% confi-
dence intervals (CIs). Pictorial presentations of the key
results were made using appropriate statistical graphs. A
two-sided P value <0.05 was considered to be statistically
significant. All statistical analyses were done using statis-
tical packages SPSS 22.0 (SPSS Inc. Chicago, IL) and Epi
Info 2000 (Centres for Disease Control and Prevention,
Atlanta, GA).
Results
Patient identification and demographics
A total of 369 children were admitted to the hospital
with a clinical diagnosis of bronchiolitis documented in
their medical charts during the study period with 261
(75.2%) aged 3 months or younger and 247 (67%) were
male sex as illustrated in Table 1. Of the 369 cases, 145
(39.3%) had a family history of atopy or asthma. On
Table 1 Demographic characteristics, clinical presentation and
symptoms, viral etiology and management of children with
acute bronchiolitis
Characteristics Frequency (%)
Gender (n = 369)
Male 247 (66.9%)
Female 122 (33.1%)
Age (months) (n = 347)
< 1 months 144 (41.5%)
1 to 3 months 117 (33.7%)
> 3 months 86 (24.8%)








Pertussis like symptoms 29 (7.9%)
Family history of atopy or asthma 145 (39.3%)
Max. Temperature (°C) (n = 353) 38.49 ± 0.80
Max. Respiratory rate (br/m) (n = 351) 62.51 ± 13.65
Max. Pulse (beat/m) (n = 351) 167.88 ± 19.18
O2 Saturation (%) (n = 341) 96.40 ± 2.46






Nationality (n = 369)
Qatari 234 (63.4%)
Non-Qatari 135 (36.6%)





Viral Etiology (n = 369)
RSV 189 (51.2%)
Influenza A 3 (0.8%)
Influenza B 1 (0.3%)
ParaInfluenza 1 4 (1.1%)
ParaInfluenza 2 4 (1.1%)
ParaInfluenza 3 19 (5.1%)
Table 1 Demographic characteristics, clinical presentation and
symptoms, viral etiology and management of children with
acute bronchiolitis (Continued)








Boca Virus 15 (4.1%)
Parechovirus 11 (3.0%)
Adenovirus 23 (6.2%)
Other viruses 20 (5.4%)
RSV Respiratory syncytial virus, RV rhinovirus, hMPV Human metapneumovirus.
Quantitative data were presented in mean ± SD. For some parameters the sum
is not equal to total n = 369 due to some missing observations and respective
% were computed based on non-missing observations
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Fig. 1 Monthly trends of respiratory viruses
Fig. 2 a Length of stay, in days, across different seasons. b Seasonal variations in hospital admission rates (%)
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admission, 348 (94.3%) and 270 (73.2%) presented
with cough and crepitation respectively, 261 (70.7%)
had fever, while 251 (68.0%) and 231 (62.6%) experi-
enced retracted breathing and wheezing respectively.
Vitals signs (mean ± SD) including temperature 38.49
± 0.80 °C, respiratory rate 62.51 ± 13.65 breaths per
minute, pulse rate 167.88 ± 19.18 bpm and O2 satur-
ation 96.40 ± 2.46% were recorded in the majority of
the children. Generally, there were no differences in
the clinical presentations between the males and the
females. However, pertussis like symptoms were more
frequently reported in females, 14/122 (11.5%), com-
pared to males, 15/247 (6.1%).
Seasonal distribution
The seasonal pattern of RSV and RV were generally distrib-
uted all year around although incidence of RSV infection
peaked during the fall season whereas RV peaked during
the spring. The findings of the current study revealed more
adenovirus (ADV) infections in the summer months than
spring (Fig. 1). Coronavirus (CoV-OC43) circulated pre-
dominantly during the winter months while parainfluenza
virus 3 (PIV3) during the fall but sporadically across the
year. Dual peaks were observed for human metapneumo-
virus (hMPV) during the spring and winter seasons.
The median LOS was longer during the summer (7 days)
compared to the winter (6 days) and shortest in the fall
and spring (5 days), Fig. 2a. Our findings show a peak in
hospital admission rates during the winter season, 154
(41.7%), followed by the fall, 138 (37.4%) with least during
the summer season, 20 (5.4%) as presented in Fig. 2b.
Viral aetiologies and multiple co-infections
We used polymerase chain reaction (PCR) to establish the
viral aetiology of acute bronchiolitis. At least one virus
was detected in 315/369 (85.4%) of children with single
virus in 211/315 (67%) and multiple viruses in 104/315
(33.0%). RSV was the most common virus identified, ac-
counting for 189 cases (51.2%) followed by RV in 94 cases
(25.5%), 23 cases (6.2%) of hMPV and ADV each. Influ-
enza A and B were the least detected viruses accounting
for less than 1% of the cases, as shown in Table 1.
Out of the 315 samples analysed, 27.3% had dual infec-
tions and three viruses were detected in 5.4% of the
sample with a quadruple infection found in one case.
There were no marked differences in the management
of single and multiple infections. β-agonists were used in
the majority of cases, followed by antibiotics, hypertonic
saline and adrenaline, presented in Table 2.
Respiratory viruses distribution by age-group, gender,
medical history and clinical presentation
Children were grouped into three age groups with differ-
ent rates of single and multiple viral infections, Table 3.
In children aged <1 month, the most common detected
virus was RSV (47.9%); for those between 1 and 3
months of age, RV (47.2%) was the most common virus.
Children aged >3 months were found to be co-infected
with RSV + RV (40%). Co-infection with RSV+ non-RV
(75.8%) had the highest incidence in males whereas in
females, RV+ non-RSV co-infection (40.9%) dominated.
Family history of atopy or asthma, P = 0.008, and high
respiratory rate, P = 0.026, were more common in RV
single group, whereas crepitation was more frequent in
the RSV+ non-RV co-infection group, P = 0.039. More
children in the RV single group (91.7%) had LOS ≥4 days
compared to the RSV single group (82.4%). Similar pat-
tern was observed in terms of bronchiolitis severity with
more children in the RV single group (65.7%) with mod-
erate to severe bronchiolitis compared to children in the
RSV single group (57.6%).
Analysis of risk factors of length of hospital stay and
bronchiolitis severity
A total of 291 (82.4) had a LOS ≥4 days. On univariate lo-
gistic regression analysis, admission during the fall season
(unadjusted OR 1.89; 95% CI 1.01,3.53; P = 0.046), cough
(unadjusted OR 7.27; 95% CI 1.2,44.5; P = 0.032), retrac-
tion (unadjusted OR 2.70; 95% CI 1.5,5.1; P = 0.002), pulse








Therapy/Treatment (n = 369)
β agonist 331 (89.7%)
Adrenaline 151 (40.9%)
0.9% saline 42 (11.4%)











Acute respiratory distress syndrome 0 (0)
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rate (unadjusted OR 1.01; 95% CI 1.0,1.03; P = 0.011) were
significantly associated with longer LOS as shown in
Table 4. Oxygen saturation level (unadjusted OR 0.78;
95% CI 0.66,0.89; P = 0.001) was associated with shorter
LOS. Detection of RV, RSV+ non-RV, age group 1–3
months and admission during the summer season in-
creased LOS but these differences did not reach statistical
significance (P >0.05). On multivariate logistic regres-
sion analysis, the only factors that remained statistically
significant were retraction (adjusted OR 3.96; 95% CI
1.64,9.59; P = 0.002), age group 1–3 months (adjusted
OR 3.09; 95% CI 1.06,9.05; P = 0.039) and high respiratory
rate (adjusted OR 1.07; 95% CI 1.0,1.14; P = 0.05), pro-
vided in Additional file 1: Table S2.
A total of 185 (53.4%) of the hospitalised children ex-
perienced moderate to severe bronchiolitis. On univari-
ate logistic regression analysis, children in this group
required greater need for respiratory support (OR 5.85;
95% CI 1.98,17.3; P = 0.001), experienced more wheezing
(OR 1.82; 95% CI 1.15,2.89; P = 0.010), crepitation (OR
3.11; 95% CI 1.64,5.90; P = 0.001), and retraction (OR
5.65; 95% CI 3.13,10.2; P <0.001), increased respiratory
rate (OR 1.09; 95% CI 1.07,1.12; P <0.001), increased
pulse rate (OR 1.03; 95% CI 1.02,1.04; P < 0.001), but
higher oxygen saturation levels reduced the odds of
moderate to severe bronchiolitis (OR 0.85; 95% CI
0.77,0.93; P = 0.001) as presented in Table 5. On multivari-
ate logistic regression analysis, crepitation (adjusted OR
9.15; 95% CI 1.58,53.13; P = 0.014), retraction (OR 4.10;
95% CI 1.05,16.12; P = 0.043), and increased respiratory
rate (adjusted OR 1.46; 95% CI 1.28,1.66; P < 0.001) were
significant predictors associated with bronchiolitis sever-
ity, provided in Additional file 1: Table S3. Complications
including atelectasis, collapse, pneumonia and sepsis were
Table 3 Demographic characteristics, clinical presentations and seasonality of acute bronchiolitis by RSV, RV and other co-infections
RSV (n = 127) RV (n = 36) RSV + RV
(n = 25)
RSV+ any other
non- RV (n = 33)
RV+ any other




Gender Male 76 (59.8) 27 (75) 15 (60) 25 (75.8) 13 (59.1) 53 (73.6) 0.180
Female 51 (40.2) 9 (25) 10 (40) 8 (24.2) 9 (40.9) 19 (26.4)
Age Group <1 months 57 (47.9) 14 (38.9) 4 (16) 8 (25) 8 (36.4) 28 (42.4) 0.064
1 to 3 months 33 (27.7) 17 (47.2) 11 (44) 12 (37.5) 8 (36.4) 23 (34.8)
>3 months 29 (24.4) 5 (13.9) 10 (40) 12 (37.5) 6 (27.3) 15 (22.7)
Nationality Qatari 90 (70.9) 22 (61.1) 16 (64) 22 (66.7) 11 (50) 42 (58.3) 0.335
Clinical and presenting
symptoms
Cough 124 (100) 35 (97.2) 25 (100) 32 (97) 22 (100) 66 (97.1) 0.408
Wheezing 83 (68) 26 (72.2) 20 (83.3) 22 (68.8) 13 (59.1) 42 (62.7) 0.471
Crepitation 88 (78.6) 30 (85.7) 22 (91.7) 25 (96.2) 16 (76.2) 56 (93.3) 0.039
Retraction 89 (76.7) 29 (82.9) 18 (75) 28 (90.3) 13 (59.1) 50 (82) 0.121
Fever 90 (74.4) 25 (71.4) 19 (79.2) 28 (87.5) 16 (80) 51 (79.7) 0.621
Apnea 8 (7.3) 1 (3.1) 3 (13) 1 (4.2) 1 (5.3) 8 (13.8) 0.415
Pertussis like symptoms 9 (8.3) 3 (11.5) 5 (20) 2 (8.3) 3 (15.8) 5 (10.2) 0.613
Family history of atopy
or asthma
54 (61.4) 20 (69) 10 (45.5) 14 (56) 3 (16.7) 29 (59.2) 0.008
Max. temperature
(degree C)
38.49 ± 0.82 38.52 ± 0.88 38.64 ± 0.77 38.49 ± 0.79 38.63 ± 0.74 38.36 ± 0.84 0.687
Max. respiratory rate
(Br/min)
61.3 ± 9.5 67.5 ± 20.1 60.3 ± 9.4 62.3 ± 7.1 59.6 ± 8.0 66.8 ± 20.5 0.026
Max. Pulse (Beat/min) 167.5 ± 15.2 170 ± 34 172.2 ± 14.8 164.2 ± 16.2 169 ± 10.8 168.4 ± 23.1 0.750
O2 Saturation 96.57 ± 2.40 95.25 ± 2.73 96.55 ± 1.60 95.8 ± 3.48 96.29 ± 1.87 96.42 ± 2.24 0.087
ICS score 3 to 4 72 (57.6) 23 (65.7) 14 (58.3) 17 (56.7) 10 (45.5) 34 (51.5) 0.692
Seasons Winter 44 (34.9) 17 (47.2) 14 (56) 13 (39.4) 11 (50) 27 (40.9) 0.483
Spring 14 (11.1) 6 (16.7) 4 (16) 3 (9.1) 0 (0) 9 (13.6)
Summer 12 (9.5) 1 (2.8) 1 (4) 2 (6.1) 2 (9.1) 2 (3)
Fall 56 (44.4) 12 (33.3) 6 (24) 15 (45.5) 9 (40.9) 28 (42.4)
Assisted ventilation Yes 12 (10) 6 (16.7) 1 (4.3) 2 (6.1) 2 (9.5) 8 (12.3) 0.642
LOS (days) ≥4 days 103 (82.4) 33 (91.7) 21 (87.5) 30 (90.9) 19 (86.4) 56 (84.8) 0.703
LOS Length of stay in hospital, ICS Initial clinical severity score. *P-values computed using one-way analysis of variance (ANOVA). Chi-square and Yates corrected
Chi-square statistical tests methods
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reported in 97 (26.3%), 76(20.6%), 63(17.1%) and 20(5.4%)
of hospitalised children respectively.
Discussion
To our knowledge this is the first comprehensive report
on viral aetiology in hospitalised children with bronchio-
litis in the State of Qatar. Our study revealed that RSV
and RV were the most commonly detected causative
agents. This finding is in contrast to a previous report
with a small sample size of 56 children with respiratory
tract infection (RTI) in Qatar in which hMPV was the
most frequently isolated virus [10]. Our findings are, how-
ever, in line with a number of large studies conducted in
the Middle East and elsewhere [11–14]. In Jordanian
Table 4 Predictors of length-of-stay ≥4 days among children with mild to severe bronchiolitis: logistic regression analysis
LOS <4 days LOS≥ 4 days Odds Ratio (OR) (95% CI) P-Value
Demographic characteristics
Age group
≤ 1 month 25 (42.4%) 118 (41.5%) 1.36 (0.70, 2.7) 0.369
1 to 3 months 15 (25.4%) 100 (35.2%) 1.92 (0.91, 4.0) 0.086
> 3 months 19 (32.2%) 66 (23.2%) 1.0 (Reference)
Male 39 (62.9%) 196 (67.4%) 1.22 (0.69, 2.15) 0.500
Female 23 (37.1%) 95 (32.6%) 1.0 (Reference)
Qatari 38 (61.3%) 185 (63.6%) 1.1 (0.63, 1.9) 0.735
Non-Qatari 24 (38.7%) 106 (36.4%) 1.0 (Reference)
Types of viruses, seasonal trend and severity
RSV 22 (50%) 103 (39.3%) 1.0 (Reference)
RV 3 (6.8%) 33 (12.6%) 2.35 (0.66, 8.35) 0.187
RSV + RV 3 (6.8%) 21 (8%) 1.50 (0.41, 5.46) 0.542
RSV+ any other non-RV 3 (6.8%) 30 (11.5%) 2.14 (0.60, 7.63) 0.243
RV+ any other non-RSV 3 (6.8%) 19 (7.3%) 1.35 (0.37, 4.97) 0.649
Others 10 (22.7%) 56 (21.4%) 1.20 (0.53, 2.70) 0.667
Seasons
Spring 8 (12.9%) 35 (12%) 1.25 (0.53, 2.90) 0.610
Summer 2 (3.2%) 18 (6.2%) 2.57 (0.57, 11.6) 0.220
Fall 18 (29%) 119 (41%) 1.89 (1.01, 3.53) 0.046
Winter 34 (54.8) 119 (40.9) 1.0 (Reference)
ICS score: 3 to 4 27 (43.5%) 156 (55.5%) 1.62 (0.93, 2.82) 0.089
ICS score: 1 to 2 35 (56.5%) 125 (44.5%) 1.0 (Reference)
Medical history and physical exam findings
Cough 59 (95.2%) 286 (99.3%) 7.27 (1.2, 44.5) 0.032
Wheezing 40 (66.7%) 189 (66.5%) 0.99 (0.55, 1.8) 0.986
Crepitation 42 (76.4%) 226 (85.6%) 1.84 (0.90, 3.7) 0.092
Retraction 33 (60%) 215 (80.2%) 2.70 (1.5, 5.1) 0.002
Fever 47 (78.3%) 212 (76.3%) 0.89 (0.45, 1.74) 0.731
Apnea 3 (5.6%) 21 (8.4%) 1.56 (0.45, 5.4) 0.485
Pertussis like symptoms 3 (5.5%) 26 (11%) 2.15 (0.63, 7.4) 0.225
Family history of asthma 22 (55%) 121 (56.3%) 1.1 (0.53, 2.1) 0.881
Maximum temperature (°C) 38.39 ± 0.87 38.52 ± 0.78 1.22 (0.86, 1.73) 0.255
Maximum respiratory rate (br/m) 60.34 ± 15.13 62.99 ± 13.32 1.02 (0.99, 1.1) 0.160
Maximum pulse rate (beat/m) 161.8 ± 22.1 169.1 ± 18.1 1.01 (1.0, 1.03) 0.011
O2 saturation (%) 97.37 ± 1.84 96.18 ± 2.53 0.78 (0.66, 0.89) 0.001
LOS Length of stay in hospital, ICS Initial clinical severity score, OR odds ratio, CI confidence interval. Dichotomous outcome LOS <4 days considered as reference group
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children of less than 2 years of age, RSV was a major cause
of hospitalisation [11]. Other studies conducted in Saudi
Arabia and Turkey reported the same [15, 16].
Geographic variations in seasonal activity of the most
commonly detected respiratory viruses have been re-
ported in the literature. In temperate countries, RSV
peaks during the winter season, but with variation in
the tropics. This diversity is mainly attributed to the
region’s climate characteristics, i.e. relative humidity,
average monthly temperature and rainfall [17–19]. In
their study, Haynes et al. assessed RSV seasonality in
seven countries with diverse climate characteristics and
found that RSV onset and peak timings were inconsist-
ent with climate characteristics in all assessed countries
Table 5 Predictors of mild to severe ICS score among children with viral bronchiolitis: logistic regression analysis
ICS score: 1 to 2 (mild) ICS score: 3 to 4 (moderate to severe) Odds Ratio (OR) (95% CI) P-Value
Demographic characteristics
Age group
≤ 1 month 70 (44.0%) 68 (38.4%) 0.84 (0.49, 1.45) 0.535
1 to 3 months 50 (31.4%) 64 (36.2%) 1.11 (0.63, 1.95) 0.720
> 3 months 39 (24.5%) 45 (25.4%) 1.0 (Reference)
Male 101 (62.7%) 131 (70.8%) 1.44 (0.92, 2.26) 0.111
Female 60 (37.3%) 54 (29.2%) 1.0 (Reference)
Qatari 97 (60.2%) 123 (66.5%) 1.31 (0.84, 2.03) 0.229
Non-Qatari 64 (39.8%) 62 (33.5%) 1.0 (Reference)
Types of viruses, seasonal trend and severity
RSV 53 (40.2%) 72 (42.4%) 1.0 (Reference)
RV 12 (9.1%) 23 (13.5%) 1.41 (0.65, 3.09) 0.389
RSV + RV 10 (7.6%) 14 (8.2%) 1.03 (0.42, 2.50) 0.947
RSV+ any other non-RV 13 (9.8%) 17 (10%) 0.96 (0.43, 2.15) 0.926
RV+ any other non-RSV 12 (9.1%) 10 (5.9%) 0.61 (0.25, 1.53) 0.293
Others 32 (24.2%) 34 (20%) 0.78 (0.43, 1.42) 0.421
Seasons
Winter 62 (38.5%) 88 (47.8%) 1.0 (Reference)
Spring 23 (14.3%) 19 (10.3%) 0.58 (0.29, 1.16) 0.124
Summer 6 (3.7%) 13 (7.1%) 1.53 (0.55, 4.24) 0.417
Fall 70 (43.5%) 64 (34.8%) 0.64 (0.40, 1.03) 0.066
LOS≥ 4 daysa 125 (78.1%) 156 (85.2%) 1.62 (0.93, 2.82) 0.089
Assisted Ventilationa 4 (2.6%) 24 (13.4%) 5.85 (1.98, 17.3) 0.001
Medical history and physical exam findings
Cough 158 (98.8%) 181 (98.4%) 0.76 (0.13, 4.63) 0.769
Wheezing 95 (60.1%) 132 (73.3%) 1.82 (1.15, 2.89) 0.010
Crepitation 109 (75.7%) 155 (90.6%) 3.11 (1.64, 5.90) 0.001
Retraction 87 (60.8%) 158 (89.8%) 5.65 (3.13, 10.2) <0.001
Fever 118 (75.6%) 135 (76.3%) 1.03 (0.63, 1.71) 0.893
Apnea 13 (9.3%) 9 (5.6%) 0.58 (0.24, 1.40) 0.224
Pertussis like symptoms 12 (9.2%) 16 (10.1%) 1.12 (0.51, 2.46) 0.782
Family history of asthma 59 (52.7%) 81 (58.3%) 1.26 (0.76, 2.07) 0.375
Maximum temperature (°C) 38.44 ± 0.82 38.56 ± 0.79 1.20 (0.92, 1.56) 0.156
Maximum respiratory rate (br/m) 57.98 ± 17.17 66.37 ± 7.83 1.09 (1.07, 1.12) <0.001
Maximum pulse rate (beat/m) 163.2 ± 19.9 171.9 ± 17.7 1.03 (1.02, 1.04) <0.001
O2 saturation (%) 96.91 ± 2.01 96.02 ± 2.64 0.85 (0.77, 0.93) 0.001
LOS Length of stay in hospital, OR odds ratio, CI confidence interval, ICS Initial clinical severity score. aReference category: LOS <4 days; not assisted ventilation.
Dichotomous outcome ICS score value 1 to 2 was taken as reference group
Janahi et al. BMC Infectious Diseases  (2017) 17:139 Page 8 of 11
apart from Thailand. RSV offset was found to be con-
sistent in Guatemala [20]. Rhinovirus A was detected
all year around with high proportion by the onset of
summer in Japan but during the fall and spring in
Cyprus while Rhinovirus C was mainly detected in the
winter but during the fall and spring in Japan and
Cyprus, respectively [18, 21].
In this study, RSV exhibited a strong seasonal pattern
with peak activity during the fall and summer months,
in contrast to RV, which showed minimal circulation
during the fall.
In comparison to children with RSV only infections,
children infected with RSV in combination with non-RV
or RV alone were more likely to have longer LOS. How-
ever, we found no significant association between single
or multiple infections and disease severity or LOS. The
findings are consistent with two large studies conducted
in North America and Europe [13, 14], but in contrast
with previous reports where RV was associated with
shorter LOS [12, 22]. These discrepancies might be re-
lated to sample size, study design and variation in host
risk factors.
In this study, we noted an association between indi-
vidual components of the clinical severity score and
bronchiolitis outcome after adjusting for clinical and
demographic factors. Similar to Ricart et al., McCallum
et al. and Weisgerber et al., the data indicate that, in
the Qatari community, children’s clinical characteris-
tics are more relevant than the specific infecting vi-
ruses in determining the duration of LOS and disease
severity [23–25].
Detection of the presence of multiple infections has be-
come common in practice although its clinical impact on
disease management and predicting outcomes remains
unclear [26]. By using RT-PCR to quantify viral load, a
number of studies have concluded that RSV genomic load
is correlated with disease severity [13, 14]. Similarly, two
investigational anti-RSV drugs showed promising results
in reducing viral load and clinical disease severity [27, 28].
Some studies have determined severity based on a
modified Wood-Downes score or the need for paediatric
intensive care unit (PICU) admission [7, 23]. In this
study we analysed severity based on a clinical score that
allows children’s classification according to respiratory
rate, oxygen saturation and physical examination, mir-
roring the severity of the respiratory burden.
Previous studies have reported males to be more sus-
ceptible than females to lower RTIs across different age
groups [29]. In this study the percent of males with se-
vere bronchiolitis was as twice as that to females, 70.8
vs. 29.2%. An explanation was suggested two decades
ago by Gupta et al. in which the disproportionally nar-
rower peripheral airways in the younger males could be
a possible mechanism of the observed difference [30].
Childhood respiratory infection may influence the
development of chronic respiratory diseases. In a co-
hort of 47 Swedish hospitalised infants with RSV-
bronchiolitis, asthma was prevalent in 30% of the group
when aged 7 years increasing to 37% at the age of 13
[31]. While Jackson et al. noted an increase in asthma
risk in children with RSV associated wheezing; RV was
associated with a 10-fold increase of asthma [32]. An
earlier retrospective study from Qatar noted an increase
in recurrent wheezing by 44% in hospitalised infants
due to RSV bronchiolitis 2 years after admission com-
pared to 12% in the control group [33]. In the current
study, 63% of the admitted children had wheezing of
which 51.2% had RSV associated bronchiolitis. Com-
pared to RSV, RV associated bronchiolitis is suggested
to occur in older infants, 13 versus 5 months, who
present more often with atopic dermatitis and blood
eosinophilia [34].
This study has potential limitations. First, it is a retro-
spective study at a single hospital. Another limitation is
that data on concomitant bacterial infection, viral genomic
load and palivizumab prophylaxis were not collected.
Conclusions
In summary, RSV was the most common virus identified,
followed by RV with peaks during the fall and spring sea-
sons respectively. Our data show that the clinical presen-
tation is more related to the duration of hospital stay and
disease severity than the detected viruses.
Conducting a prospective, multi site surveillance of
viral bronchiolitis in the warm, desert climate of the
Gulf Cooperation Council (GCC) countries will allow
for proper timing of preventable measures. Future stud-
ies within the GCC countries should investigate the
interplay between climate characteristics, population’s
factors and the most detectable circulating viruses.
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